The effects of nucleoside/nucleotide analogues on host immune cells: the baseline for future immune therapy for HBV?
{{output}}
HBV is a non-cytopathic virus and the progression of liver fibrosis is attributed to the host immune response. Complete suppression of viral replication using nucleotide or nucleoside analogues (NUCs) can prevent most complications related to chronic HBV infec... ...
